Collectively, our results demonstrate that the metabolic enzyme HPD acts as a non‐canonical RBP to promote global mRNA translation efficiency in ovarian cancer, adding another dimension to the regulation of ovarian cancer development of HPD with moonlighting function. Here, HPD is linked to ovarian carcinoma.